Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| Invesco Nasdaq Biotechnology ETF | IBBQ | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 21.93 | 06:10:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.93 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 18.18 - 23.02 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| - | 0 | 21.93 | USD |
Invesco Nasdaq Biotechnology ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 32.24M | - | - | - | 16.11 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Invesco Nasdaq Biotechno...
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
IBBQ Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.88 | 22.04 | 20.88 | 21.86 | 16,018 | 1.05 | 5.03% |
| 1 Month | 21.23 | 22.04 | 20.14 | 21.26 | 10,646 | 0.70 | 3.30% |
| 3 Months | 21.75 | 23.02 | 20.14 | 21.98 | 17,715 | 0.18 | 0.83% |
| 6 Months | 19.45 | 23.02 | 18.34 | 21.71 | 18,070 | 2.48 | 12.75% |
| 1 Year | 21.41 | 23.02 | 18.18 | 21.34 | 12,275 | 0.52 | 2.43% |
| 3 Years | 25.61 | 27.77 | 16.73 | 21.92 | 15,329 | -3.68 | -14.37% |
| 5 Years | 25.61 | 27.77 | 16.73 | 21.92 | 15,329 | -3.68 | -14.37% |
| The Invesco Nasdaq Biotechnology ETF (the Fund) seeks to track theinvestment results (before fees and expenses) of the Nasdaq BiotechnologyIndex (the Underlying Index). The Fund generally will invest at least 90% of its total assets in thesecurities that comprise the Underlying Index.Strictly in accordance with its guidelines and mandated procedures,Nasdaq, Inc. (Nasdaq or the Index Provider) compiles the UnderlyingIndex, which is a modified market capitalization weighted index that isdesigned to measure the performance of securities listed on the NasdaqStock Market that are classified as either biotechnology or pharmaceuticalcompanies. Eligible securities must be classified under the biotechnologysubsector or pharmaceuticals subsector of the Industry ClassificationBenchmark (ICB), have a minimum market capitalization of $200 millionat the time of the Underlying Indexs annual rebalancing, and have aminimum average daily trading volume of 100,000 shares. |
